US 9938236
Antiviral agents against HBV infection
granted A61PA61P1/16A61P31/12
Quick answer
US patent 9938236 (Antiviral agents against HBV infection) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/16, A61P31/12, A61P31/14, A61P31/20